Clinical trial
Clinical Study of R744 to Predialysis Patients( Phase III, Comparative Study in…
NCT00492427 · Chugai Pharmaceutical, Industry · Completed
Key facts
| NCT number | NCT00492427 |
|---|---|
| Title | Clinical Study of R744 to Predialysis Patients( Phase III, Comparative Study in Comparison With Epoetin Beta) |
| Official title | Correction and Maintenance Study of Subcutaneous Injections of R744 to Predialysis Patients ( Phase III, Comparative Study in Comparison With Epoetin Beta) |
| Lead sponsor | Chugai Pharmaceutical, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Predialysis Patients |
| Intervention type | Drug |
| Interventions | R744, Epoetin beta |
| Enrollment | 187 |
| Start date | Jun 1, 2007 |
| Primary completion | Jan 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | Jun 27, 2007 |
| Last update posted | Jan 8, 2009 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: